Study Results and Webinars

We will regularly update this page with links to our publications and participant webinars:

Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients (June 25, 2021)

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series (June 15, 2021)

Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients (April 9, 2021)

Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients (Mar 15, 2021)

Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients (Feb 4, 2021)

Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study (Jan 19, 2021)

Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients (August 24, 2021)

SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipient (August, 2021)

SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19 (November, 2021)

Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients (October, 2021)

Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination is Solid Organ Transplant Recipients (October, 2021)

Six-month Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients (October, 2021)

Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination with Ad.26.COV2.S in Solid Organ Transplant Recipients: A Case Series (November, 2021)

A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients

Six-month Antibody Kinetics and Durability After Three Doses of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series (December, 2021)

Improved Antibody Response to a Fifth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients

Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lunch Transplant Recipients


Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept (March, 2022)

A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response (April, 2022)

Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An Update

Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination (April, 2022)

Antibody Response to Three SARS-CoV-2 mRNA Vaccines in Adolescent Solid Organ Transplant Recipients

Webinars for study participants include study updates and Q&A:

March 23, 2021

May 14, 2021

July 8, 2021

February 23, 2022